About Manisha Chatterjee

Since she was young, Manisha has had a strong interest in the stock market. She majored in Economics in college and has a passion for writing, which has led to her career as a research analyst. Manisha’s goal is to help individual investors succeed in the stock market. She uses her knowledge in fundamental analysis to evaluate companies and determine if they are worthwhile investments.


Recent Articles By Manisha Chatterjee

: IQV |  News, Ratings, and Charts

Does Healthcare Stock IQVIA Holdings Belong in Your Portfolio?

Most industrial sectors worldwide are pursuing rapid digitalization and the healthcare sector is no exception. Consequently, we think it wise to bet on healthcare services company IQVIA Holdings (IQV), which is strategically positioned to gain from the increasing use of advanced analytics and AI in the healthcare space.
: SONO |  News, Ratings, and Charts

Is Sonos Still a Good Stock to Buy?

Audio concern Sonos, Inc. (SONO) has delivered exceptional returns over the past year due to a change in consumer behavior amid the pandemic. The stock is expected to hit fresh highs because demand for its audio products is on the rise. Let’s look closer at the company.
: PGR |  News, Ratings, and Charts

Is Progressive a Good Insurance Stock to Own in 2021?

Property and casualty insurer Progressive (PGR) has outperformed during the pandemic. The stock is well-positioned to deliver significant returns in the upcoming months based on the rising demand for its flexible and bundled insurance offerings because of the revival of the auto industry and rising residential property purchases.
: PENN |  News, Ratings, and Charts

Is Penn National Gaming Still a Good Stock to Bet On?

As sports betting and online wagering becomes legalized in more states, Penn National Gaming (PENN) is positioned for even further growth. However, the stock’s high valuation coupled with weak financials amid a competitive environment poses a question regarding its future growth.
: LYV |  News, Ratings, and Charts

Up 20% YTD, Will the Rally in Live Nation Entertainment Stock Continue?

Live Nation Entertainment’s (LYV) impressive rally so far this year has been based primarily on investor optimism surrounding the reopening of live entertainment in response to increasing control of the COVID-19 pandemic and a broad economic recovery. However, as the U.S.’ recovery is far from complete, and the company’s financials don’t justify its current price level, we think the stock might witness a pullback in the near term. Let’s take a closer look.
: CAH |  News, Ratings, and Charts

Is Now a Good Time to Buy Cardinal Health Stock?

Cardinal Health (CAH) has not only managed to stay afloat amid much market uncertainty but reported revenue growth across its segments in its last-reported quarter. So, I think it is wise to bet on the stock now because it is trading at a discount to its peers and could generate healthy ROI in the near term.
: QRVO |  News, Ratings, and Charts

Qorvo: A 5G Stock Worth Buying

The 5G market is growing at an accelerated pace and we think Qorvo (QRVO) is positioned nicely to benefit significantly from this based on its sound financials, market dominance and continued product innovation. The company is expected to witness greater demand for its chips in the upcoming months. Let’s take a closer look at how Qorvo rolls.
: NTDOY |  News, Ratings, and Charts

Is Nintendo a Good Video Game Stock to Add to Your Portfolio?

Nintendo (NTDOY), a dominant player in the home entertainment products space, boasts influential franchises such as Mario and the Legend of Zelda. Given the positive outlook for the video game space, we think NTDOY is positioned to continue gaining.
: INTU |  News, Ratings, and Charts

Is Intuit Still a Good Stock to Buy?

The demand for Intuit’s (INTU) products and services is expected to increase with the rising importance of financial management in the digital realm. We think this, coupled with the company’s inorganic growth and profitability, should help the stock keep climbing to new highs. Let’s discuss.
: SNY |  News, Ratings, and Charts

Sanofi: Is Now a good Time to Buy this Pharmaceutical Stock?

Sanofi (SNY) is a top player in the healthcare space. We think it should thrive this year and beyond based on its expertise in the research and development of therapies. So, it is wise to add the stock to your portfolio because it is trading at a discount.
Page generated in 1.4164 seconds.